These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 36457249)
1. Engineering of efficiency-enhanced Cas9 and base editors with improved gene therapy efficacies. Yin S; Zhang M; Liu Y; Sun X; Guan Y; Chen X; Yang L; Huo Y; Yang J; Zhang X; Han H; Zhang J; Xiao MM; Liu M; Hu J; Wang L; Li D Mol Ther; 2023 Mar; 31(3):744-759. PubMed ID: 36457249 [TBL] [Abstract][Full Text] [Related]
2. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing. Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144 [TBL] [Abstract][Full Text] [Related]
3. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing. Chadwick AC; Wang X; Musunuru K Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1741-1747. PubMed ID: 28751571 [TBL] [Abstract][Full Text] [Related]
4. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo. Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914 [TBL] [Abstract][Full Text] [Related]
5. Versatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9. Liu Z; Chen S; Xie W; Song Y; Li J; Lai L; Li Z Mol Ther; 2022 Jan; 30(1):256-267. PubMed ID: 34174445 [TBL] [Abstract][Full Text] [Related]
6. Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG. Zhong Z; Sretenovic S; Ren Q; Yang L; Bao Y; Qi C; Yuan M; He Y; Liu S; Liu X; Wang J; Huang L; Wang Y; Baby D; Wang D; Zhang T; Qi Y; Zhang Y Mol Plant; 2019 Jul; 12(7):1027-1036. PubMed ID: 30928637 [TBL] [Abstract][Full Text] [Related]
7. Multiplex nucleotide editing by high-fidelity Cas9 variants with improved efficiency in rice. Xu W; Song W; Yang Y; Wu Y; Lv X; Yuan S; Liu Y; Yang J BMC Plant Biol; 2019 Nov; 19(1):511. PubMed ID: 31752697 [TBL] [Abstract][Full Text] [Related]
8. Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia. Ma SP; Gao XX; Zhou GQ; Zhang HK; Yang JM; Wang WJ; Song XM; Chen HY; Lu DR Gene; 2022 Apr; 820():146289. PubMed ID: 35143940 [TBL] [Abstract][Full Text] [Related]
9. Compact Cje3Cas9 for Efficient Chen S; Liu Z; Xie W; Yu H; Lai L; Li Z CRISPR J; 2022 Jun; 5(3):472-486. PubMed ID: 35686977 [TBL] [Abstract][Full Text] [Related]
10. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements. Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953 [TBL] [Abstract][Full Text] [Related]
11. Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery. Kweon J; Jang AH; Kwon E; Kim U; Shin HR; See J; Jang G; Lee C; Koo T; Kim S; Kim Y Exp Mol Med; 2023 Feb; 55(2):377-384. PubMed ID: 36720917 [TBL] [Abstract][Full Text] [Related]
12. Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non-PI domain mutations derived from xCas9. Xie L; Hu Y; Li L; Jiang L; Jiao Y; Wang Y; Zhou L; Tao R; Qu J; Chen Q; Yao S FEBS J; 2022 Oct; 289(19):5899-5913. PubMed ID: 35411720 [TBL] [Abstract][Full Text] [Related]
13. FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity. Cui Z; Tian R; Huang Z; Jin Z; Li L; Liu J; Huang Z; Xie H; Liu D; Mo H; Zhou R; Lang B; Meng B; Weng H; Hu Z Nat Commun; 2022 Mar; 13(1):1425. PubMed ID: 35301321 [TBL] [Abstract][Full Text] [Related]
14. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing. Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357 [TBL] [Abstract][Full Text] [Related]
15. Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences. Hua K; Tao X; Han P; Wang R; Zhu JK Mol Plant; 2019 Jul; 12(7):1003-1014. PubMed ID: 30928636 [TBL] [Abstract][Full Text] [Related]
16. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs. Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958 [TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-based multiplex genome editing of BCL11A and HBG efficiently induces fetal hemoglobin expression. Han Y; Tan X; Jin T; Zhao S; Hu L; Zhang W; Kurita R; Nakamura Y; Liu J; Li D; Zhang Z; Fang X; Huang S Eur J Pharmacol; 2022 Mar; 918():174788. PubMed ID: 35093321 [TBL] [Abstract][Full Text] [Related]
18. Editing Properties of Base Editors with SpCas9-NG in Discarded Human Tripronuclear Zygotes. Liu X; Zhou X; Li G; Huang S; Sun W; Sun Q; Li L; Huang X; Liu J; Wang L CRISPR J; 2021 Oct; 4(5):710-727. PubMed ID: 34661426 [TBL] [Abstract][Full Text] [Related]
19. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants. Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740 [TBL] [Abstract][Full Text] [Related]